November 5, 2019

Preclinical results support the therapeutic potential of KB-1801 for the prevention of Cardiac Surgery-Associated Acute Kidney Injury and advancement into clinical development.

CAMBRIDGE, Mass., November 4, 2019 - Kantum Pharma Inc., a biopharmaceutical company focused...

Please reload

Recent Posts
Please reload

© 2019 Kantum Pharma

Registered trademark of Kantum Pharma, Inc